NeoGenomics Announces Fourth Quarter and Full Year 2008 Financi... ( FT. MYERS Fla. March 5 /- NeoGenomics...)

NeoGenomics Announces Fourth Quarter and Full Year 2008 Financial Results

Date:3/5/2009

FT. MYERS, Fla., March 5 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (NASD OTC Bulletin Board: NGNM), an operator of a network of cancer-focused testing laboratories, today announced its results for the fourth quarter and full-year ended December 31, 2008.

Fourth Quarter 2008 Highlights:

Revenue of $5.9 million, an increase of 56% year-over-year from Q4 07
17.2% sequential increase in revenues in Q4 08 vs. Q3 08
Avg. Rev/Requisition increased 13.7% in Q4 08 from Q4 07
Avg. Rev/Test increased 9.6% in Q4 08 from Q4 07
Development of in-house molecular testing capability

Fiscal Year 2008 Highlights:

Revenue of $20.0 million, an increase of 74% year-over-year from FY 07
Avg. Rev/Requisition increased 15% in FY 08 from FY 07
Avg. Rev/Test increased 12.3% in FY 08 from FY 07
Days Sales Outstanding (DSO) declined to 45 days on 12/31/08 from 79 on 12/31/07

Fourth Quarter 2008

Revenues increased 56.0% year-over-year to $5.9 million in Q4 08 from Q4 07. Requisitions increased 37.2% and average revenue/requisition increased 13.7% to $819.77. Gross profit increased 65.8% to approximately $3.1 million in Q4 08. Gross profit margin increased by 310 basis points to 53.1% in Q4 08 from 50.0% in Q4 07. Selling, general and administrative ("SG&A") expenses increased 11.0% to approximately $3.8 million. However, SG&A expenses as a percentage of revenue fell to 64.8% in Q4 08 from 91.1% in Q4 07. Net loss decreased by approximately $601,000 to ($994,000) or ($0.03)/share in Q4 08 from ($1,596,000) or ($0.05/share) in Q4 07.

SG&A expenses in the fourth quarter
'/>"/>

0

GOOD

Page: 1 2 3 4 5 6 7 8
Related biology technology :

1. NeoGenomics Announces Results for the Fourth Quarter and Full Year FY 2007
2. NeoGenomics Files Annual Report on Form 10-KSB with the SEC
3. NeoGenomics Schedules Its Q1 2008 Earnings Release for May 7, 2008
4. NeoGenomics Schedules its Q2 2008 Earnings Release for July 31, 2008
5. NeoGenomics to Present at the Rodman & Renshaw Healthcare Conference on November 10
6. NeoGenomics Schedules its Q4 and Full Year 2008 Earnings Release for March 5, 2009
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
9. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
10. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
11. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets

Post Your Comments:

NeoGenomics Announces Fourth Quarter and Full Year 2008 Financi...( FT. MYERS Fla. March 5 /- NeoGenomics...)